Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation

Recruiting now

Conditions studied: Atrial Fibrillation

In brief

In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.

Key facts

Study ID

NCT05638841

Run by

Peking University Third Hospital

People needed

300

Starts

2023-01-01

Expected to finish

2026-12-31

Last updated by the study team

2024-02-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1) Age > 18
• 2) ECG or holter electrocardiogram confirmed atrial fibrillation

You may not qualify if…

• 1) Hematological diseases, autoimmune diseases and malignant tumors
• 2) Immobility caused by hemiplegia or severe trauma
• 3) The expected survival time is less than 2 years
• 4) Poor compliance and high risk of expected loss of follow-up
• 5) Disorders of consciousness or Alzheimer's disease

Where it is running

• Peking-University-Third-Hospital — Beijing, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.